Background: Over 5% of newborn infants born worldwide need help initiating breathing. Exhaled carbon dioxide (ECO 2 ) may be the earliest signal that an infant is receiving effective facemask ventilation. ECO 2 levels in healthy infants in the first minutes after birth are unknown. Our aim is to measure ECO 2 in spontaneously breathing infants ?35weeks from the first breath after birth, through the first hours after birth.
Methods: This was a single-centre observational study. We used a respiratory function monitor to measure ECO 2 via a facemask in healthy newborns starting with the first breath after birth through 10 minutes after birth and at 1 hour after birth.
Results ), median weight = 3350 g (IQR 3030-3692), 52% male, 57% delivered by elective caesarean section. The facemask was applied at median time of 1 s (IQR − 5-2) after birth, as the head was often exposed prior to complete delivery. The first cry occurred at 4 s (IQR 0-22.5). ECO 2 was first recorded at 7 breaths (IQR 4-11), ECO 2 > 15 mmHg at 9 breaths Cerebral Palsy Alliance Background: Up to 20% of children with congenital heart disease (CHD) who undergo cardiac surgery develop neurodevelopmental disabilities (NDD), with a number of studies reporting persistent impairment. While abnormal fetal cerebral blood and perioperative factors are contributors, it is becoming increasingly apparent that patient genotype plays an important role. In this study, the genetic link between heart and brain development was investigated.
Method: A gene panel comprising 148 genes implicated in CHD and/or NDD was designed. Using massively parallel sequencing technology, 15 patients with CHD + NDD (as determined by the Bayley Scales of Infant and Toddler Development Version-III), 15 patients with CHD and normal development and 15 healthy controls were screened. Poisson log-linear regression analyses was used to compare the number and types of variants between the three groups.
Results: A significant increase in rare variants (MAF < 0.01) was identified between the CHD + NDD cohort (p < 0.001) and CHD only cohort (p = 0.04) compared with controls. There was also a significant increase in novel and low frequency variants (MAF < 0.05) between the CHD + NDD cohort and controls (p = 0.001 and p < 0.001 respectively). Furthermore, individual variant analysis identified a number of pathogenic variants in CHD + NDD and CHD cases.
Conclusions: The findings suggest that an increase in novel, rare and low frequency variants in genes linked to CHD and/or NDD are associated with NDD in patients with CHD. Individual variant analysis as well as gene and pathway specific analyses will identify variants/genes/groups of genes conferring the highest risk of CHD AE NDD development. Method: Case review.
MANAGEMENT OF HEREDITARY FRUCTOSE INTOLERANCE IN PREGNANCY
Results: This 24 year-old woman was diagnosed with HFI at eight years of age. She presented in her first pregnancy at eight weeks gestation. Her pregnancy was managed by the maternal fetal medicine team in conjunction with a clinical geneticist and an endocrinologist. Early pregnancy was complicated by hypoglycaemic episodes that required hospitalisation. These were treated with dietary modifications and mannose supplementation. The patient had a body mass index of 27 and weight gain of 16 kilograms in pregnancy. Antenatal pharmacy review of all potential medications was undertaken, revealing many potentially dangerous medications. The patient presented in spontaneous labour at 39 weeks gestation and progressed to a Ventouse delivery of a 3735 g male infant. Post-partum haemorrhage of 2200 ml occurred secondary to uterine atony. The infant was transferred to the neonatal intensive care unit following an episode of hypoglycaemia at four hours.
Conclusions: HFI is a rare medical condition and management in pregnancy requires multidisciplinary input with unique considerations and close monitoring.
